The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer
Currently, lung cancer is a global problem and public health issue in the world. Chemoradiotherapy remains the optimal method in the treatment of patients with unresectable non-small cell lung cancer (NSCLC). Nowadays, immune response checkpoint inhibitors (monoclonal antibodies) are actively introd...
Main Authors: | E. I. Smolenov, G. V. Afonin, V. S. Usachev, D. D. Kudryavtsev, I. V. Kolobaev, S. A. Ivanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2021-06-01
|
Series: | Issledovaniâ i Praktika v Medicine |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/727 |
Similar Items
-
Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy
by: Vrankar Martina, et al.
Published: (2018-02-01) -
Immunotherapy in inoperable stage III non-small cell lung cancer: a review
by: Natasha A Jain, et al.
Published: (2019-06-01) -
Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
by: Tania Crombet Ramos, et al.
Published: (2020-05-01) -
Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
by: Anissa Roger, et al.
Published: (2018-07-01) -
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
by: Jessica Cusato, et al.
Published: (2019-01-01)